AbbVie | ABBV - Stock

Stock Price
211.59
Daily Change
5.22 2.53%
Monthly
-6.97%
Yearly
17.65%
Q2 Forecast
202.55

AbbVie reported $4.95B in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
AbbVie USD 4.95B 13M Dec/2025
Abbott USD 6.49B 220M Dec/2025
ALKERMES USD 196.62M 5.63M Dec/2025
Amgen USD 6.22B 121M Dec/2025
AstraZeneca USD 6.59B 126M Sep/2025
Biogen USD 2.17B 41.3M Dec/2025
BioMarin Pharmaceutical USD 1.3B 83.29M Dec/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Coherus Biosciences USD 3.17M 1.12M Dec/2025
Eisai JPY 236.46B 9.14B Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Gilead Sciences USD 1.78B 40M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Infinity Pharmaceuticals USD 0 0 Sep/2021
J&J USD 14.19B 45M Dec/2025
Medtronic USD 6.31B 153M Dec/2025
Merck USD 6.44B 157M Sep/2025
Neurocrine Biosciences USD 69M 300K Dec/2025
Novartis USD 6.42B 114M Sep/2025
Pacira USD 152.86M 4.82M Dec/2025
Perrigo USD 1.15B 78M Dec/2025
Pfizer USD 11.47B 201M Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 22.69B 1.81B Dec/2025
UCB EUR 1.31B 173M Dec/2024
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
United Therapeutics USD 183.1M 6.6M Dec/2025
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025
Zoetis USD 2.43B 35M Dec/2025